Invention Grant
- Patent Title: Dihydroartemisinin diploid derivative, pharmaceutical composition thereof, and application
-
Application No.: US16488568Application Date: 2018-04-11
-
Publication No.: US11136339B2Publication Date: 2021-10-05
- Inventor: Xinsong Li , Ma Si , Longbing Ling
- Applicant: SOUTHEAST UNIVERSITY
- Applicant Address: CN Nanjing
- Assignee: SOUTHEAST UNIVERSITY
- Current Assignee: SOUTHEAST UNIVERSITY
- Current Assignee Address: CN Nanjing
- Agency: CBM Patent Consulting, LLC
- Priority: CN201710115410.4 20170228
- International Application: PCT/CN2018/082649 WO 20180411
- International Announcement: WO2018/157874 WO 20180907
- Main IPC: C07D519/00
- IPC: C07D519/00 ; A61P17/06 ; A61P19/02 ; A61P33/06 ; A61P35/00 ; C07F9/655

Abstract:
Disclosed are a dihydroartemisinin dimer derivative, a pharmaceutical composition, and an application thereof. The derivative is an artemisinin dimer used for drugs treating or preventing malaria caused by plasmodium, drugs treating autoimmune diseases such as lupus erythematosus, and anti-tumour drugs, which is a pharmaceutical composition prepared from the dihydroartemisinin dimer derivative and a pharmaceutically acceptable carrier.
Public/Granted literature
- US20200040008A1 DIHYDROARTEMISININ DIPLOID DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION Public/Granted day:2020-02-06
Information query